Question

In: Chemistry

A novel chimeric monoclonal antibody (Nocatmab) has been developed for the treatment of tetanospasmin toxicity, one...

A novel chimeric monoclonal antibody (Nocatmab) has been developed for the treatment of tetanospasmin toxicity, one of the most potent and dangerous toxins known in modern medicine. Each molecule of Nocatmab inactivates four molecules of tetanospasmin. Knowing that the lethal dose for tetanospasmin is 2.5 ng/kg for a human adult, and that the MW (Molecular Weight) of tetanospasmin is 150,020 amu, can you calculate the minimal dose of Nocatmab (MW 348,055 amu) required to treat a subject who weighs 63 kg and has recieved a lethal dose of tetanospasmin?

Solutions

Expert Solution

Solution :-

Lets first calculate the mass of the tetanospasmin in 63 kg adult

63 kg * 2.5 ng per kg = 157.5 ng

157.5 ng * 1 g / 1*10^9 ng = 1.575*10^-7 g

Lets calculate the moles

Moles = mass/ molar mass

Moles of tetanospasmin = 1.575*10^-7 g * 1 mol / 150020 g per mol

                                            = 1.05*10^-12 mol

1 molecule of Nocatmab inactivates four molecules of tetanospasmin

So moles of the nocatmab needed are

1.05*10^-12 mol tetanospasmin * 1 mol Nocatmab / 4 mol tetanospasmin = 2.625*10^-13 moles

Now lets convert the moles of the Nocatmab to its mass

Mass= moles * molar mass

         = 2.625*10^-13 mol * 348055 g per mol

         = 9.14*10^-8 g

Lets convert the g to ng

9.14*10^-8 g * 1*10^9 ng / 1 g = 91.4 ng

So to treat the 63 kg adult it need 91.4 ng of the Nocatmab


Related Solutions

"monoclonal antibody can be used as a therapeutic agent for the treatment of cancer"- justify the...
"monoclonal antibody can be used as a therapeutic agent for the treatment of cancer"- justify the statement with an appropriate example
How would a monoclonal antibody to a viral protein be prepared?
How would a monoclonal antibody to a viral protein be prepared?
Immunoassays can use polyclonal or monoclonal antibody preparations. a) How do polyclonal antibodies differ from monoclonal...
Immunoassays can use polyclonal or monoclonal antibody preparations. a) How do polyclonal antibodies differ from monoclonal antibodies? (Marks: 2) b) Describe one immunoassay that requires the use of polyclonal antibodies. (Marks: 4) c) Describe one immunoassay that requires the use of monoclonal antibodies. (Marks: 4)
You raise a monoclonal antibody to a protein that is highly expressed in germinating pollen grains...
You raise a monoclonal antibody to a protein that is highly expressed in germinating pollen grains of Brassica napus. Outline the procedure that you would use to identify the location of this protein within cells.
Herceptin is a monoclonal antibody based drug that binds a receptor present in many copies on...
Herceptin is a monoclonal antibody based drug that binds a receptor present in many copies on the cells of certain aggressive and early onset breast cancers. a. How does this immunotherapy treatment approach work? b. How is it different from standard chemotherapy?
Using diagrams, describe the differences between a chimeric and humanised human-mouse monoclonal antibody.
Using diagrams, describe the differences between a chimeric and humanised human-mouse monoclonal antibody.
Which conditions may be treated with monoclonal antibody (mAb) therapy? (Select all that apply.) Group of...
Which conditions may be treated with monoclonal antibody (mAb) therapy? (Select all that apply.) Group of answer choices Heart murmur Hemophilia Asthma Breast cancer
What is the order for monoclonal antibody production? Growth of hybridoma cells Plasma cells isolated from...
What is the order for monoclonal antibody production? Growth of hybridoma cells Plasma cells isolated from mouse spleen Growth of plasma cells Immunisation of mouse spleen Growth of myeloma cells Fusion of plasma cells and myeloma cells
A new drug has been developed to treat a particular condition, and it is alleged to be more effective than traditional treatment.
  A new drug has been developed to treat a particular condition, and it is alleged to be more effective than traditional treatment. An experiment will be conducted to test whether the claim is true. To perform the hypothesis test, a 99% confidence level is selected for the hypothesis test. The new drug will be administered to a sample of 200 individuals with the condition, selected at random. Another 300 individuals are randomly selected to receive the traditional treatment. Of...
0.5 mg/ml of rabbit anti-HIV gp120 monoclonal antibody. Dilute to a working concentration of 2 ug/ml...
0.5 mg/ml of rabbit anti-HIV gp120 monoclonal antibody. Dilute to a working concentration of 2 ug/ml in 1x PBS. Please show math and work 0.5 mg/ml of rabbit anti-HIV gp120 monoclonal antibody conjugated to HRP. Dilute to a working concentration of 0.5 ug/ml in 1x PBS. Please show math and work.
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT